SCHEMBL10503014

SCHEMBL10503014

CC(C)(CCNC(=O)CCCO[N+](=O)[O-])NCC(O)COc1cccc2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 4/20 0.48
▸ ADRB2 P07550 7/20 0.45
▸ ADRB1 P08588 7/20 0.45
▸ SIGMAR1 Q99720 4/20 0.45
▸ ADRB3 P13945 4/20 0.45
▸ CYP1A2 P05177 3/20 0.45
▸ SLC6A4 P31645 3/20 0.45
▸ HTR2B P41595 3/20 0.45
▸ NR2E1 Q9Y466 3/20 0.45
▸ ALDH1A1 P00352 3/20 0.45
▸ HTR2A P28223 3/20 0.45
▸ HTR2C P28335 3/20 0.45
▸ HTR6 P50406 3/20 0.45
▸ SCN1A P35498 2/20 0.45
▸ SLC10A1 Q14973 2/20 0.45
▸ SCN2A Q99250 2/20 0.45
▸ SCN3A Q9NY46 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ HTR1A P08908 2/20 0.45
▸ LMNA P02545 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10503702 0.91 CYP2D6 (0.49) CYP2D6ADRB2ADRB1SIGMAR1ADRB3
SCHEMBL10594588 0.81 CYP2D6 (0.45) CYP2D6ADRB2ADRB1ADRB3CYP1A2
SCHEMBL10592061 0.81 CASR (0.50) ADRB2ADRB1ADRB3CYP1A2ALDH1A1
SCHEMBL10504761 0.81 L3MBTL1 (0.47) ADRB2ADRB1ADRB3ALDH1A1SMN1; SMN2
SCHEMBL10505401 0.80 ADRB2 (0.40) ADRB2ADRB1ADRB3CYP1A2LMNA
SCHEMBL10594410 0.79 ADRB2 (0.42) ADRB2ADRB1ADRB3CYP1A2
SCHEMBL10505383 0.79 ADRB2 (0.42) ADRB2ADRB1ADRB3
SCHEMBL10592973 0.79 CASR (0.49) ADRB2ADRB1ADRB3CYP1A2SMN1; SMN2
SCHEMBL10504268 0.79 ADRB2 (0.44) CYP2D6ADRB2ADRB1ADRB3CYP1A2
SCHEMBL10592902 0.79 ADRB2 (0.37) CYP2D6ADRB2ADRB1ADRB3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0200915-B1 AMINOPROPANOL DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AND MEDICINES CONTAINING THEM Roche Diagnostics GmbH (DE) 1989-09-27 — — EP disclosed
US-4863949-A CARDIOVASCULAR DISORDER TREATMENT BOEHRINGER MANNHEIM GMBH (DE) 1989-09-05 — — US disclosed
EP-0200915-A1 Aminopropanol derivatives, process for their preparation, their use and medicines containing them Roche Diagnostics GmbH (DE) 1986-11-12 — — EP disclosed
Send feedback